Search

Search Constraints

You searched for: Author/Creator Papoutselis, Menelaos

Search Results

2. Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher‐risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes. Issue 4 (26th June 2020)

3. Multifaceted modes of action of azacytidine: a riddle wrapped up in an enigma. Issue 13 (10th November 2019)

4. Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study. Issue 1 (1st July 2020)

5. Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study. Issue 1 (1st July 2020)

6. Risk factors for cardiovascular disease mortality in patients with myelodysplastic syndromes: A nationwide, registry‐based cohort study. Issue 1 (1st July 2020)

7. Serum ferritin and ECOG performance status predict the response and improve the prognostic value of IPSS or IPSS-R in patients with high-risk myelodysplastic syndromes and oligoblastic acute myeloid leukemia treated with 5-azacytidine: a retrospective analysis of the Hellenic national registry of myelodysplastic and hypoplastic syndromes. (December 2020)